Literature DB >> 22265892

Maladaptive matrix remodeling and regional biomechanical dysfunction in a mouse model of aortic valve disease.

Varun K Krishnamurthy1, Amy M Opoka, Christine B Kern, Farshid Guilak, Daria A Narmoneva, Robert B Hinton.   

Abstract

Aortic valve disease (AVD) occurs in 2.5% of the general population and often requires surgical intervention. Aortic valve malformation (AVM) underlies the majority of cases, suggesting a developmental etiology. Elastin haploinsufficiency results in complex cardiovascular problems, and 20-45% of patients have AVM and/or AVD. Elastin insufficient (Eln+/-) mice demonstrate AVM and latent AVD due to abnormalities in the valve annulus region. The objective of this study was to examine extracellular matrix (ECM) remodeling and biomechanical properties in regional aortic valve tissue and determine the impact of early AVM on late AVD in the Eln+/- mouse model. Aortic valve ECM composition and remodeling from juvenile, adult, and aged stages were evaluated in Eln+/- mice using histology, ELISA, immunohistochemistry and gelatin zymography. Aortic valve tissue biomechanical properties were determined using micropipette aspiration. Cartilage-like nodules were demonstrated within the valve annulus region at all stages identifying a developmental abnormality preceding AVD. Interestingly, maladaptive ECM remodeling was observed in early AVM without AVD and worsened with late AVD, as evidenced by increased MMP-2 and MMP-9 expression and activity, as well as abnormalities in ADAMTS-mediated versican processing. Cleaved versican was increased in the valve annulus region of aged Eln+/- mice, and this abnormality correlated temporally with adverse alterations in valve tissue biomechanical properties and the manifestation of AVD. These findings identify maladaptive ECM remodeling in functional AVM as an early disease process with a progressive natural history, similar to that seen in human AVD, emphasizing the importance of the annulus region in pathogenesis. Combining molecular and engineering approaches provides complementary mechanistic insights that may be informative in the search for new therapeutic targets and durable valve bioprostheses. Copyright Â
© 2011 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265892      PMCID: PMC3295865          DOI: 10.1016/j.matbio.2012.01.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  53 in total

1.  The aortic outflow and root: a tale of dynamism and crosstalk.

Authors:  M H Yacoub; P J Kilner; E J Birks; M Misfeld
Journal:  Ann Thorac Surg       Date:  1999-09       Impact factor: 4.330

2.  RECS1 is a negative regulator of matrix metalloproteinase-9 production and aged RECS1 knockout mice are prone to aortic dilation.

Authors:  Hanjun Zhao; Akihiko Ito; Naohiko Sakai; Yuji Matsuzawa; Shizuya Yamashita; Hiroshi Nojima
Journal:  Circ J       Date:  2006-05       Impact factor: 2.993

3.  Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition.

Authors:  Elizabeth H Stephens; Nicky de Jonge; Meaghan P McNeill; Christopher A Durst; K Jane Grande-Allen
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

4.  Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination.

Authors:  F J Schoen
Journal:  J Heart Valve Dis       Date:  1997-01

5.  Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

Authors:  Loren E Dupuis; Daniel R McCulloch; Jessica D McGarity; Alexandria Bahan; Andy Wessels; Deidra Weber; A Megan Diminich; Courtney M Nelson; Suneel S Apte; Christine B Kern
Journal:  Dev Biol       Date:  2011-07-01       Impact factor: 3.582

6.  Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation.

Authors:  Mervyn J Merrilees; Brent W Beaumont; Kathleen R Braun; Anita C Thomas; Inkyung Kang; Aleksander Hinek; Alberto Passi; Thomas N Wight
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

7.  Zonal uniformity in mechanical properties of the chondrocyte pericellular matrix: micropipette aspiration of canine chondrons isolated by cartilage homogenization.

Authors:  Farshid Guilak; Leonidas G Alexopoulos; Mansoor A Haider; H Ping Ting-Beall; Lori A Setton
Journal:  Ann Biomed Eng       Date:  2005-10       Impact factor: 3.934

Review 8.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

9.  Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet.

Authors:  Jun Liao; Erinn M Joyce; Michael S Sacks
Journal:  Biomaterials       Date:  2008-03       Impact factor: 12.479

10.  Elastic fibers in the aortic valve spongiosa: a fresh perspective on its structure and role in overall tissue function.

Authors:  H Tseng; K J Grande-Allen
Journal:  Acta Biomater       Date:  2011-01-19       Impact factor: 8.947

View more
  9 in total

Review 1.  Decellularized matrices for cardiovascular tissue engineering.

Authors:  Francesco Moroni; Teodelinda Mirabella
Journal:  Am J Stem Cells       Date:  2014-03-13

2.  Differential cell-matrix responses in hypoxia-stimulated aortic versus mitral valves.

Authors:  Matthew C Sapp; Varun K Krishnamurthy; Daniel S Puperi; Saheba Bhatnagar; Gabrielle Fatora; Neelesh Mutyala; K Jane Grande-Allen
Journal:  J R Soc Interface       Date:  2016-12       Impact factor: 4.118

3.  Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease.

Authors:  Brynn N Akerberg; Maithri L Sarangam; Kryn Stankunas
Journal:  Dev Biol       Date:  2015-06-20       Impact factor: 3.582

4.  Proteomic Alterations Associated with Biomechanical Dysfunction are Early Processes in the Emilin1 Deficient Mouse Model of Aortic Valve Disease.

Authors:  P M Angel; D A Narmoneva; M K Sewell-Loftin; C Munjal; L Dupuis; B J Landis; A Jegga; C B Kern; W D Merryman; H S Baldwin; G M Bressan; Robert B Hinton
Journal:  Ann Biomed Eng       Date:  2017-08-15       Impact factor: 3.934

Review 5.  Review of molecular and mechanical interactions in the aortic valve and aorta: implications for the shared pathogenesis of aortic valve disease and aortopathy.

Authors:  Varun K Krishnamurthy; Richard C Godby; G R Liu; J Michael Smith; Loren F Hiratzka; Daria A Narmoneva; Robert B Hinton
Journal:  J Cardiovasc Transl Res       Date:  2014-11-20       Impact factor: 4.132

6.  Development of myotendinous-like junctions that anchor cardiac valves requires fibromodulin and lumican.

Authors:  Loren E Dupuis; Lorna Doucette; A Kittrell Rice; Ashton E Lancaster; Matthew G Berger; Shukti Chakravarti; Christine B Kern
Journal:  Dev Dyn       Date:  2016-08-25       Impact factor: 3.780

7.  Exome sequencing in multiplex families with left-sided cardiac defects has high yield for disease gene discovery.

Authors:  David M Gordon; David Cunningham; Gloria Zender; Patrick J Lawrence; Jacqueline S Penaloza; Hui Lin; Sara M Fitzgerald-Butt; Katherine Myers; Tiffany Duong; Donald J Corsmeier; Jeffrey B Gaither; Harkness C Kuck; Saranga Wijeratne; Blythe Moreland; Benjamin J Kelly; Vidu Garg; Peter White; Kim L McBride
Journal:  PLoS Genet       Date:  2022-06-23       Impact factor: 6.020

8.  TGF-β mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease.

Authors:  Charu Munjal; Amy M Opoka; Hanna Osinska; Jeanne F James; Giorgio M Bressan; Robert B Hinton
Journal:  Dis Model Mech       Date:  2014-08       Impact factor: 5.758

9.  Early Aberrant Angiogenesis Due to Elastic Fiber Fragmentation in Aortic Valve Disease.

Authors:  Robert B Hinton; Amy L Juraszek; Amy M Opoka; Benjamin J Landis; J Michael Smith; Robert P Mecham; Kevin E Bove
Journal:  J Cardiovasc Dev Dis       Date:  2021-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.